Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check3 days agoChange DetectedThe history now shows a new revision entry v3.3.4 and the removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedNew history entries dated 2025-12-24 and 2025-12-23 add Study Status and Contacts/Locations. An earlier entry dated 2025-06-13 was removed.SummaryDifference0.4%

- Check25 days agoChange DetectedAdded a new Revision: v3.3.3 entry and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check47 days agoChange DetectedThe latest version shows Revision: v3.3.2 replacing v3.3.1 in the Record History; this is a minor metadata update with no visible changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.3.1 has been added to the record history. The v3.2.0 revision entry has been removed.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved a site-wide funding/operating status banner. The change does not alter the study data or the information presented in the record history.SummaryDifference0.6%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.